Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duane A Mitchell

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Seminars in Immunopathology|February 1, 2017
The development of dendritic cell vaccine-based immunotherapies for glioblastomaDavid A Reardon, Duane A Mitchell
Brain Sciences|October 26, 2017
Immunotherapy for Pediatric Brain TumorsElias J Sayour, Duane A Mitchell
Cytotherapy|October 18, 2016
Gene-modified dendritic cell vaccines for cancerRebecca S Abraham, Duane A Mitchell
Current Treatment Options in Oncology|October 13, 2018
Immunotherapy for Brain TumorsLan B Hoang-Minh, Duane A Mitchell
Cancers|January 23, 2024
Comment on Mahajan, S.; Schmidt, M.H.H. Distinct Lineage of Slow-Cycling Cells Amidst the Prevailing Heterogeneity in Glioblastoma. <i>Cancers</i> 2023, <i>15</i>, 3843Changlin Yang, Duane A Mitchell, Loic P Deleyrolle
Oncoimmunology|November 11, 2017
Translational nanoparticle engineering for cancer vaccinesAdam J Grippin, Elias J Sayour, Duane A Mitchell
Neuro-Oncology|May 8, 2018
Temozolomide for immunomodulation in the treatment of glioblastomaAida Karachi, Farhad Dastmalchi, Duane A Mitchell, et al.
Cancer Journal (Sudbury, Mass.)|September 4, 2003
Adoptive immunotherapy for malignant gliomaDuane A Mitchell, Peter E Fecci, John H Sampson
Targeted Oncology|January 29, 2021
Vaccine Therapies for Cancer: Then and NowMichael A Morse, William R Gwin, Duane A Mitchell
Oncoimmunology|August 8, 2014
Immunological targeting of cytomegalovirus for glioblastoma therapySmita K Nair, John H Sampson, Duane A Mitchell
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Seminars in Immunopathology|February 1, 2017
The development of dendritic cell vaccine-based immunotherapies for glioblastomaDavid A Reardon, Duane A Mitchell
Brain Sciences|October 26, 2017
Immunotherapy for Pediatric Brain TumorsElias J Sayour, Duane A Mitchell
Cytotherapy|October 18, 2016
Gene-modified dendritic cell vaccines for cancerRebecca S Abraham, Duane A Mitchell
Current Treatment Options in Oncology|October 13, 2018
Immunotherapy for Brain TumorsLan B Hoang-Minh, Duane A Mitchell
Cancers|January 23, 2024
Comment on Mahajan, S.; Schmidt, M.H.H. Distinct Lineage of Slow-Cycling Cells Amidst the Prevailing Heterogeneity in Glioblastoma. <i>Cancers</i> 2023, <i>15</i>, 3843Changlin Yang, Duane A Mitchell, Loic P Deleyrolle
Oncoimmunology|November 11, 2017
Translational nanoparticle engineering for cancer vaccinesAdam J Grippin, Elias J Sayour, Duane A Mitchell
Neuro-Oncology|May 8, 2018
Temozolomide for immunomodulation in the treatment of glioblastomaAida Karachi, Farhad Dastmalchi, Duane A Mitchell, et al.
Cancer Journal (Sudbury, Mass.)|September 4, 2003
Adoptive immunotherapy for malignant gliomaDuane A Mitchell, Peter E Fecci, John H Sampson
Targeted Oncology|January 29, 2021
Vaccine Therapies for Cancer: Then and NowMichael A Morse, William R Gwin, Duane A Mitchell
Oncoimmunology|August 8, 2014
Immunological targeting of cytomegalovirus for glioblastoma therapySmita K Nair, John H Sampson, Duane A Mitchell
Pageof 13